Profil
Bobby V.
Khan is the founder of InVasc Therapeutics, Inc. founded in 2006.
He is currently the Director of Cardiovascular Research at Grady Memorial Hospital, the Executive Director at Carmel Biosciences, Inc., and a Professor at Emory University.
Dr. Khan's former positions include being a Principal at the American College of Cardiology Foundation and the American Heart Association (New York).
He received his undergraduate degree from Vanderbilt University and his doctorate from the University of Tennessee.
Postes actifs de Bobby V. Khan
| Sociétés | Poste | Début |
|---|---|---|
Grady Memorial Hospital
Grady Memorial Hospital Hospital/Nursing ManagementHealth Services Operates hospital | Corporate Officer/Principal | 12/07/2010 |
Emory University
Emory University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 12/07/2010 |
Carmel Biosciences, Inc.
Carmel Biosciences, Inc. BiotechnologyHealth Technology Develops drugs from novel compounds | Directeur/Membre du Conseil | - |
Anciens postes connus de Bobby V. Khan
| Sociétés | Poste | Fin |
|---|---|---|
American College of Cardiology Foundation
American College of Cardiology Foundation Medical/Nursing ServicesHealth Services Provides cardiovascular education services | Corporate Officer/Principal | - |
American Heart Association (New York)
American Heart Association (New York) Miscellaneous Commercial ServicesCommercial Services Provides public health educational services | Corporate Officer/Principal | - |
InVasc Therapeutics, Inc.
InVasc Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Develops drugs to treat or prevent cardiometabolic disease | Fondateur | - |
Formation de Bobby V. Khan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
InVasc Therapeutics, Inc.
InVasc Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Develops drugs to treat or prevent cardiometabolic disease | Health Technology |
Vanderbilt University
Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Emory University
Emory University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Tennessee
University of Tennessee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American College of Cardiology Foundation
American College of Cardiology Foundation Medical/Nursing ServicesHealth Services Provides cardiovascular education services | Health Services |
Grady Memorial Hospital
Grady Memorial Hospital Hospital/Nursing ManagementHealth Services Operates hospital | Health Services |
American Heart Association (New York)
American Heart Association (New York) Miscellaneous Commercial ServicesCommercial Services Provides public health educational services | Commercial Services |
Carmel Biosciences, Inc.
Carmel Biosciences, Inc. BiotechnologyHealth Technology Develops drugs from novel compounds | Health Technology |
















